Nektar enters ATM equity distribution agreement for up to $75M

NEKTAR THERAPEUTICS

ATM equity distribution agreement with Piper Sandler and BTIG allows sale of up to $75M of common stock.
Shares sold via at-the-market offerings on Nasdaq; agents receive 3.0% commission on gross proceeds.
Company has no obligation to sell any shares; either party may suspend or terminate the offering.
Registration statement on Form S-3 filed on March 28, 2025, for the offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.